Lung cancer has a high morbidity rate worldwide due to its resistance to therapy. So new
treatment options are needed to improve the outcomes of lung cancer treatment. This study …

Lung cancer remains among the most difficult-to-treat malignancies and is the leading cause
of cancer-related deaths worldwide. The introduction of targeted therapies and checkpoint …

Abstract α-Hederin is a monosaccharide pentacyclic triterpene saponin compound derived
from the Chinese herb, Pulsatilla. It has garnered considerable attention for its anti-tumor …

Introduction Immune-checkpoint inhibitors (IO) have significantly improved outcomes of
patients with non-oncogene-addicted non-small cell lung cancer (NSCLC), becoming the …

Immune checkpoint inhibitors (ICIs) target the negative regulatory pathway of T cells and
effectively reactive the anti-tumor immune function of T cells by blocking the key pathway of …

Simple Summary Lung cancer is the leading cause of cancer-related death worldwide.
Despite treatment advances, high rates of tumor recurrence emphasize the need for new …

Lung cancer remains the most common cause of cancer death. Given the continued
research into new drugs and combination therapies, outcomes in lung cancer have been …

Microsatellite Instability, Mismatch Repair, and Tumor Mutation Burden in Lung Cancer -
Surgical Pathology Clinics Skip to Main Content Skip to Main Menu Advertisement Surgical …

Lung tumors are one of the most aggressive threats affecting humans. Current therapeutic
approaches have improved patients' survival; however, further efforts are required to …

Oncolytic viral immunotherapy is gaining considerable prominence in the realm of chronic
diseases treatment and rehabilitation. Oncolytic viral therapy is an intriguing therapeutic …